About Bend Bioscience
Bend Bioscience is a company based in Bend (United States). It operates as a Professional Services. Bend Bioscience has completed 1 acquisition, including IriSys. Bend Bioscience offers products and services including Oral Bioavailability Enhancement, Multiparticulates, and Modified Release.
- Headquarter Bend, United States
- SectorsHealthcare
- Website recrocdmo.com
- Social LinkedIn
- Investments & Acquisitions
Products & Services of Bend Bioscience
Bend Bioscience offers a comprehensive portfolio of products and services, including Oral Bioavailability Enhancement, Multiparticulates, and Modified Release.
Solutions for enhancing oral bioavailability are developed expertly.
Multiparticulate formulations are created for optimized drug delivery.
Modified release formulations are designed for controlled delivery.
Investments & Acquisitions by Bend Bioscience
Bend Bioscience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include IriSys.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract development and manufacturing of pharmaceutical dosage forms are offered. | irisys.com | San Diego, United States | 1996 | Aug 2021 | •••• |
Complete acquisition details for Bend Bioscience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Similar companies to Bend Bioscience
10 companies that operate in the same segment as Bend Bioscience (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bend Bioscience
Bend Bioscience is headquartered in Bend, United States. It is registered at Bend, Oregon, United States.
Bend Bioscience is involved in providing contract development and manufacturing services for pharmaceutical products. Expertise is offered in oral bioavailability enhancement, multiparticulates, and modified release formulations. Services span from design and development to clinical and commercial manufacturing. Solutions are provided for complex oral dosage forms, oral solids, liquids, powders for inhalation, and topicals. Operations are conducted across multiple U.S. locations, focusing on innovative problem-solving and quality compliance.
Bend Bioscience offers Oral Bioavailability Enhancement, Multiparticulates, and Modified Release.
Bend Bioscience has made 1 acquisition, including IriSys.